Vital Capacity Can Be Used to Evaluate Recovery From a Myocardial Infarction

Continuing Education Activeness

Pulmonary edema refers to the accumulation of excessive fluid in the alveolar walls and alveolar spaces of the lungs. It tin can be a life-threatening status in some patients with loftier mortality and requires immediate assessment and management. This activeness reviews the pathophysiology, clinical presentation, evaluation, and direction of cardiogenic pulmonary edema and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.

Objectives:

Depict the etiology and pathophysiology of cardiogenic pulmonary edema.
Summarize the clinical findings and differential diagnosis of cardiogenic pulmonary edema.
Review the management and complications of cardiogenic pulmonary edema.
Explain the function of Interprofessional team to better the delivery and outcome of the management provided for better outcomes in patients with cardiogenic pulmonary edema.

Access gratis multiple choice questions on this topic.

Introduction

Edema refers to excessive fluid accumulation in the interstitial spaces, beneath the skin or within the trunk cavities caused by any of the following and producing significant signs and symptoms.[1]

An imbalance among the "Starling forces"
Damage/blockage of the draining lymphatic organisation

The afflicted trunk part usually swells if edema is present beneath the peel or produces significant signs and symptoms related to the body cavity involved.

There are several different types of edema, and few important are the peripheral edema, pulmonary edema, cognitive edema, macular edema, and lymphedema. The atypical forms are the idiopathic edema and hereditary angioneurotic edema.

Pulmonary edema refers to the accumulation of excessive fluid in the alveolar walls and alveolar spaces of the lungs. It can be a life-threatening condition in some patients.[ii] Pulmonary edema can be:

Cardiogenic (disturbed starling forces involving the pulmonary vasculature and interstitium)
Non-Cardiogenic (direct injury/harm to lung parenchyma/vasculature)

Etiology

All the factors which contribute to increased force per unit area in the left side and pooling of blood on the left side of the centre tin can cause cardiogenic pulmonary edema.[3] The event of all these conditions will exist increased pressure on the left side of the eye: increased pulmonary venous pressure--> increased capillary pressure level in lungs--> pulmonary edema.[4]

Coronary artery disease with left ventricular failure (myocardial infarction)
Congestive center failure
Cardiomyopathy
Valvular heart diseases on the leftside of the heart (stenosis and regurgitation)
Cardiac arrhythmias
Right to left shunts

Epidemiology

Pulmonary edema is a life-threatening condition with an estimated 75000 to 83000 cases per 100000 persons having heart failure and depression ejection fraction. A trial showed an alarming lxxx% prevalence of pulmonary edema in patients with middle failure.[5] It is a troublesome status with the rate of belch being 74% and the rate of survival later on one yr of 50%.[6]. The mortality charge per unit at half-dozen years follow upwards was 85% with patients of congestive heart failure. Males are typically affected more females, and the elderly are at a higher risk for developing pulmonary edema.[vii]

Pathophysiology

Cardiogenic form of pulmonary edema (pressure-induced) produces a non-inflammatory type of edema by the disturbance in Starling forces. The pulmonary capillary pressure is 10mm Hg (range: 6 to 13) in normal weather, but any factor which increases this pressure can cause pulmonary edema.[8] The alveoli are normally kept dry considering of the negative pressure in actress-alveolar interstitial spaces, but when there is[9]:

Increased force per unit area/pooling--> Increased pulmonary venous pressure--> Increased pulmonary capillary pressure--> fluid in interstitial spaces--> Increased pressure in Interstitial spaces--> fluid in alveoli (pulmonary edema).

Pulmonary capillary wedge pressure level tin be measured, graded, and will produce unlike presentations on Ten-rays.

Histopathology

The chief features seen on microscopy are[x]:

Alveolar wall thickening
Dilated capillaries and interstitial edema
Transudation in the alveolar lumen (granular and pale eosinophilic)

History and Physical

Patients normally present with shortness of jiff, which may exist astute in onset (from minutes to hours) or gradual in onset occurring over hours to days, depending upon the etiology of pulmonary edema.

Acute pulmonary edema will have[11]:

Excessive shortness of breath worsening on exertion or lying down
A feeling of the sinking of heart and drowning/anxiety worsening on lying downwardly
Gasping for breath
Dizziness and excessive sweating
A cough may be associated with worsening edema
Blood tinged/pinkish colored frothy sputum in very severe disease
Chest hurting (myocardial infarction and aortic dissection)
Cold, clammy skin

Chronic pulmonary edema volition have:

Shortness of jiff on exertion
Orthopnea
Paroxysmal nocturnal dyspnea
Swelling of the torso/lower extremities
Weight gain
Fatigue

Ortner syndrome, which refers to hoarseness due to compression of recurrent laryngeal nerve considering of an enlarged left atrium, may besides exist occasionally present in some patients.

Concrete Examination

On exam, the positive findings include:

General advent

Confusion, agitation, and irritability may exist present, associated with excessive sweating, cold extremities, and upright posture (sitting upright), cyanosis of the lips.

JVP/JVD

Unremarkably raised.

Blood Force per unit area

Hypertension is more often nowadays, but if hypotension prevails, information technology is an indicator of severe left ventricular systolic dysfunction, and cardiogenic daze must be ruled out. Cold extremities are a feature of low perfusion and shock.

Respiratory Rate

Tachypnea is usually present, with the patient gasping for breath.

Pulse

Tachycardia (increased heart/ pulse rate) and associated finding of the crusade in the pulse.

Pedal Edema

Ordinarily co-exists with pulmonary edema in chronic eye failure.

Respiratory Findings

Dyspnea and tachypnea are commonly nowadays, may be associated with the utilise of accessory muscles of respiration. Fine crackles are commonly heard at the bases of lungs bilaterally, and progress apically as the edema worsens. Ronchi and wheeze may also be presenting signs.

Cardiovascular Findings
- Tachycardia and hypotension may be present along with jugular venous distention. Auscultation of the heart helps to differentiate between the various causes of valvular lesions causing pulmonary edema.
- Auscultation typically reveals an S3 gallop in volume overload states, which may be associated with accentuation of the pulmonic component of S2.
- Several dissimilar types of murmurs can exist heard depending upon the cause of the valvular lesion.
- Mitral stenosis produces a low pitched, rumbling diastolic murmur associated with an opening snap at the noon which becomes accentuated on expiration and produces loud S1.
- Mitral regurgitation produces a blowing, high pitched pan-systolic murmur best heard at the apex, radiating to left axilla and accentuating on expiration, produces soft S1.
- Aortic stenosis produces a harsh crescendo-decrescendo ejection systolic murmur at the aortic expanse, increasing on expiration commonly radiating towards the right side of the neck.
- Aortic regurgitation produces a high pitched blowing early diastolic murmur all-time heard during expiration heard of the aortic surface area.

Gastrointestinal System

Tender hepatomegaly may exist a feature in cases of right-sided cardiac failure, which may worsen to hepatic fibrosis and hepatic cirrhosis in chronic congestion. Ascites may sometimes be present.

Evaluation

No unmarried definitive exam is available for diagnosing pulmonary edema but clinically one gain from simple to the more complex tests while searching for the diagnosis and the associated etiology.

Blood Tests[12]

CBC (to dominion out anemia and sepsis)
Serum electrolytes (patients on diuretic therapy may accept disturbances )
Pulse oximetry and ABGs (assessing hypoxia and oxygen saturation)
BNP (brain natriuretic peptide levels: low levels rule out cardiogenic type )

ECG

Used to rule out ischemic changes and rhythm abnormalities.

Radiologic Investigations[13]

Chest X-ray (It is one of the nearly of import investigations required for the evaluation of pulmonary edema and overload states.

Early Stage

In the early stages, cardiomegaly is present, usually identified every bit an increase of cardiothoracic ratio over l%.
Broad vascular pedicle
Vascular redistribution
Cephalization

Intermediate Stage

Interstitial edema
Kerley B lines
Peribronchial cuffing
Thickened interlobar fissure

Late Stage

Alveolar edema
Perihilar batwing appearance
Pleural effusion

Ultrasonography

Ultrasonography may exist helpful in farther strengthening of diagnosis. Transthoracic ultrasound commonly differentiates COPD from CCF as a cause of acute exacerbation of chronic dyspnea.

Echocardiography [14]

Extremely important in determining the etiology of cardiogenic pulmonary edema. It differentiates systolic from diastolic dysfunction and valvular lesions.

Cardiac tamponade
Acute papillary muscle rupture
Acute ventricular septal defect
Valvular lesions

Invasive Technique

Pulmonary Arterial Catheter

A Swan-Ganz catheter is inserted into the peripheral vein and avant-garde farther till the branch of the pulmonary artery is reached, and then the pulmonary capillary wedge pressure is measured.

Treatment / Management

General Management[15]

ABC must be addressed initially as the patient arrives.

Airway assessment( Brand sure the airway is clear for adequate oxygenation and ventilation)
Breathing ( Note the blueprint of breathing and oxygen saturation.)
Apportionment ( Vital sign and cardiac cess and management )
Oxygen commitment and ventilatory back up (Through nasal cannula, face mask, non-rebreather mask, noninvasive pressure support ventilation, and mechanical ventilation every bit required)
Prop up
Intra-venous access
Urine output monitoring

After initial airway clearance, oxygenation assessment, and maintenance, management mainly depends upon presentation and should be tailored from patient to patient. Supplemental oxygen is a requirement if the patient is at risk of hypoxemia (SPO2 less than 90% ). Unnecessary oxygen should not exist administered as it causes vasoconstriction and reduction in cardiac output. Supplemental oxygen if necessary should be given in the post-obit order:

Nasal cannula and face mask ---> Non-rebreather mask ---> Trial of non-invasive ventilation (NIV) ---> Intubation and mechanical ventilation

If the respiratory distress and hypoxemia go along on oxygen supplementation, a trial of non-invasive ventilation should follow if there are no contraindications of NIV, equally testify suggests that information technology lowers the demand for intubation and improves respiratory parameters. If the patient does not meliorate or have contraindications to NIV, then intubation and mechanical ventilation (with high positive end-expiratory pressure level) should be considered.

Specific Direction[16][17]

Handling of the underlying cause.
Non Invasive Management
Invasive Direction

Non-Invasive Management[18]can exist achieved past:

Pre-Load Reduction which tin can be achieved past:

Nitroglycerin
Sodium nitroprusside
Isosorbide dinitrate
Loop diuretics (furosemide, torsemide, bumetanide)
Morphine and nesiritide require farthermost care.
BIPAP can assistance motility the fluid out of the lungs by increasing the intrapulmonary pressure

Later on initial resuscitation and management, the mainstay of treatment in acute settings is diuresis with or without vasodilatory therapy. The aggressiveness of treatment depends upon the initial presentation, hemodynamic, and volume status of the patient. VTE prophylaxis is more often than not indicated in patients admitted with acute middle failure. Sodium brake is also necessary for patients with HF.

Patients presenting with acute decompensated eye failure (ADHF) with features of pulmonary edema should be treated with intravenous diuretics initially, regardless of the etiology. Patients with HF and features of pulmonary edema receiving treatment with early on assistants of diuretics had better outcomes co-ordinate to guidelines of the American College of Cardiology Foundation/ American Heart Clan Chore Force.[19] A prospective observational study suggested that early treatment with furosemide in patients with AHF lowers the in-infirmary mortality, and the bloodshed increased with delay in the time of administration.[20] Diuretic therapy for patients who have not received diuretics previously is equally follows:

If renal function is acceptable:

Furosemide: 20 to 40 mg Iv
Torsemide: x to xx mg 4
Bumetanide: ane mg Iv

If renal function is deranged/astringent HF:

Furosemide: upwardly to 160 to 200 mg IV bolus, or can be given every bit 5 to 10mg/60 minutes baste.
Torsemide: up to 100 to 200 mg IV bolus
Bumetanide: 4 to viii mg IV bolus

If the patient shows normal renal role, and there is very little/no response to initial treatment, the dose of diuretics should be doubled at 2-hr intervals until achieving the maximum recommended.

The patients who are on chronic diuretic therapy should receive college doses of diuretics in acute settings. The initial dose for such patients should be greater than ii times of daily maintenance dose. A continuous infusion can as well be used as an alternative to bolus therapy if the patient responds to the bolus dose.

While being managed in hospital for pulmonary edema IV diuresis can be used using loop diuretics. Furosemide is the usual drug of pick. While diuresis, one should monitor the post-obit:

Daily weight
Strict intake and output measures
Telemetry
A basic metabolic panel including kidney functions and electrolytes
Proceed serum potassium above iv.0 mEq/L and Mg over 2.0 mEq/Fifty.
Continuous pulse ox if indicated
Renal functions

In add-on to diuretic therapy, vasodilator therapy may exist necessary Indications include:

Urgent afterload reduction ( astringent hypertension )
Adjunct to diuretics when the patient doesn't respond to diuretic therapy lonely
For patients with refractory center failure and decreased cardiac output

Vasodilator therapy has to exist used with slap-up caution since it can cause symptomatic hypotension, and the evidence of its efficacy and safety is very limited. When they are needed, they should be used with great caution while monitoring hemodynamic response under expert opinion.

Nitrates (nitroglycerin and isosorbide dinitrate) cause greater venodilation than arterio-dilation and can be used intravenously in recommended doses. Nitroglycerin tin can be used at 5 to ten mcg/min initially and tin be increased gradually to the maximum recommended dose (200 mcg/min) while closely monitoring the hemodynamic responses. Isosorbide dinitrate has a much longer half-life than nitroglycerin, which puts it at a disadvantage if the drug requires discontinuation considering of the symptomatic hypotension.

Sodium nitroprusside causes both venous and arterio-dilation and can significantly lower the claret force per unit area. Information technology requires shut hemodynamic monitoring through an intra-arterial catheter. It is used initially in a dose of 5 to ten mcg/min, which can be titrated up to 400mcg/min, which is the maximum recommended dose. At higher doses, it increases the chance of cyanide toxicity. Hence it has to exist used with extreme circumspection and with close monitoring under expert supervision.

Nesiritide should not routinely be a therapeutic option for the handling of HF. A large randomized trial fusing nesiritide in patients of acutely decompensated middle failure (ADHF) shows that information technology was not associated with whatever change in the charge per unit of death or rehospitalization, increased risk of hypotension and a small non-significant change in dyspnea.[21] Nesiritide, if used, should exist used initially as an intravenous bolus of 2mcg/kg and afterward a continuous infusion 0.01mcg/kg.

Salt and water restriction is generally indicated for patients with HF.

Vasopressor receptor antagonist (tolvaptan) can too exist used with caution and nether supervision.

Afterwards-Load Reduction which can be achieved past:

ACE inhibitors or angiotensin receptor-neprilysin inhibitor (ARNI): captopril, enalapril, lisinopril, perindopril, etc.
ARBs (angiotensin receptor blockers): valsartan, telmisartan, olmesartan, candesartan, etc.
Sodium nitroprusside

ACE inhibitors or ARNI is the mainstay of chronic treatment for patients with HFrEF. If the patient doesn't tolerate ACE-inhibitors or ARNI, so ARB should exist considered the get-go-line choice for prolonged treatment. Beta-blockers and mineralocorticoid receptor antagonists crave extra care if used.

If claret force per unit area is depression, start ionotropic agents, and vasopressors (catecholamines and phosphodiesterase inhibitors) should commence. The handling for centre failure with reduced ejection fraction (HFrEF) differs from middle failure with preserved ejection fraction. (HFpEF).

For patients of HFrEF presenting with hypotension, intense hemodynamic monitoring is necessary. The patient should undergo evaluation for signs of shock (confusion, cold extremities, decreased urine output, etc.). If the patient of HFrEF has signs of hypotension and/or blood pressure less than 80mmg, Ionotropes should exist added immediately and titrated accordingly. For patients of persistent shock, vasopressors as well have to exist added.

For the patients of HFpEF, but vasopressors are necessary. Inotropes are NOT indicated in patients with HFpEF and dynamic left ventricular obstruction (well-nigh commonly hypertrophic obstructive cardiomyopathy).

Invasive Management[14]

IABP (intra-aortic balloon pump)
Ultrafiltration
Ventricular help devices
ECMO (extracorporeal membrane oxygenation)
Cardiac transplant
Valve replacement (in case of valvular bug)
PCI (percutaneous coronary intervention)
CABG (coronary artery featherbed graft)
Intubation (if required to maintain the airway and besides helps in moving the fluid out)

In a patient of astringent HFrEF with acute hemodynamic compromise and cardiogenic shock, mechanical cardiac support is available while waiting on a decision or waiting on recovery hence called " bridge to the decision and "span to recovery." The patients ordinarily accept blood pressure less than 90mmHg, PCWP greater than 18mmHg, and a cardiac alphabetize of less than 2L/min per meter foursquare.

IABP (intra-aortic airship pump) is the device that is used most commonly amongst the mechanical circulatory devices every bit it is least expensive, easily insertable, and readily available. It consists of a airship in the aorta that inflates and deflates synchronously with the heartbeat causing increased cardiac output and coronary menstruum. IABPs are used commonly for temporary circulatory support with patients of advanced eye failure while waiting for a heart transplant or VADs. It is non a definitive therapy merely is widely used as a bridge therapy for patients with cardiogenic shock and too every bit an adjunct to thrombolysis in astute myocardial infarction for stabilization.

Ventricular assist devices every bit compared to IABP have greater efficacy in increasing the hemodynamic parameters. These have more complications and require more expertise, have longer to insert and cost more than in comparison. They are an option in astute decompensated heart failure. They can too be useful in complications of acute heart failure similar cardiogenic shock, mitral regurgitation, and VSDs. They can be unlike kinds like left ventricle to the aorta, left atrium to the aorta, correct ventricular assist device, etc.

Ultrafiltration (UF) is the most effective approach for sodium, and h2o removal effectively improves hemodynamics in patients of heart failure. UF is the process of abstracting plasma water from the whole blood across a hemofilter considering of the transmembrane pressure gradient. It is preferred over diuretics because information technology removes sodium and water more effectively and does not stimulate the neurohormonal activation through macula densa. UF is used in patients with HF equally information technology decreases PCWP, restores diuresis, reduces diuretic requirements, corrects hyponatremia, improves cardiac output, and thus improves congestion.[22] In some patients of heart failure, UF was associated with improved cardiac index and oxygenation capacity, decreased PCWP, and less need for inotropes.[23] Several types of UF are isolated, intermittent, and continuous. The continuous blazon tin piece of work in an arterio-venous or veno-venous way, which is the almost common type.

UF can be crucial in patients with centre failure and resistance to diuretic therapy and tin can serve to optimize the volume status. Many questions regarding UF crave test in further studies, and the show does not support its widespread employ as a substitute for diuretics.[24]

Differential Diagnosis

Differential Diagnosis includes[25]:

Respiratory failure
Myocardial ischemia/infarct
Pulmonary embolism
Neurogenic pulmonary edema
High altitude pulmonary edema
Acute respiratory distress syndrome

Prognosis

Prognosis mainly depends on the underlying cause only generally has a poor prognosis. Cardiogenic pulmonary edema is an alarming condition with the charge per unit of belch beingness 74% and the rate of survival after one year of l%.[6] The mortality charge per unit at 6 years follow-up is 85% with patients of congestive middle failure.[7]

Complications

Most complications of pulmonary edema arise from the complications of the underlying crusade. Mutual complications associated with cardiogenic etiologies include:

Chance of arrhythmias (atrial fibrillation, ventricular fibrillation, ventricular tachycardias)
Thromboembolism (pulmonary embolism, DVT, stroke)
Pericarditis
Rupture
Valvular heart disease
Cardiogenic stupor
Tamponade
Dressler syndrome
Death

Pulmonary edema can cause astringent hypoxia and hypoxemia leading to finish-organ damage and multi-organ failure. Respiratory failure is another mutual complexity of cardiogenic pulmonary edema.

Deterrence and Patient Education

As cardiac events are the prime factors for the evolution of pulmonary edema, patients are advised to control and prevent the progression of heart illness past:

Healthy lifestyle and exercise
Smoking cessation
Booze cessation
Weight reduction and monitoring
Proper diet control
Low cholesterol diet
Reducing salt intake
Blood force per unit area control
Adept glycemic control

Enhancing Healthcare Team Outcomes

Pulmonary edema can be a very life-threatening condition, and specialized consultation is a requirement for diagnosis and management. Considering a very loftier short term bloodshed rate, an Interprofessional team arroyo is recommended in the direction of these patients to meliorate outcomes.

Starting from the diagnosis, etiological factor, and direction of the patient, a well-coordinated team needs to work for ameliorate patient care involving all the related departments. All the available treatment options need to exist discussed to avoid whatsoever complications and improving the effect. The use of non-invasive positive force per unit area ventilation has a significant benefit in acute cardiogenic pulmonary edema.[26] [Level-ii]

While the doctor is involved primarily in the management of the patient, consultation is also necessary from a team of specialists involving cardiologists, pulmonologists, and cardiothoracic surgeons. The nurses are also a vital fellow member of the interprofessional group, as they will monitor the patient's vital signs, and communicate back to the team with results. The nurse practitioner, similar the primary care provider, follows these patients in an outpatient setting and should try and reduce the risk factors for ischemic heart illness. Patients should be urged to quit smoking, enroll in cardiac rehabilitation, maintain healthy body weight, become physically active, and remain compliant with follow upward appointments and medications. A dietary consult should be obtained to educate the patient on a healthy diet and what foods to avoid.

Since most patients with center failure are no longer able to work, social work assistance is crucial then that the patient can go the much needed medical support.

The role of pharmacists will exist to ensure that the patient is on the right medication and dosage. The radiologist can likewise play a vital role in determining the cause of dyspnea. A mental wellness nurse should consult with the patient because depression and anxiety are mutual morbidities, leading to poor quality of life.

As shown higher up, cardiogenic pulmonary edema requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, other ancillary therapists (respiratory, social worker), and pharmacists, all collaborating across disciplines to accomplish optimal patient results. [Level 5]

If the patient is deemed to exist a candidate for a ventricular assist device or heart transplant, the transplant nurse should be involved early on in the care. With a shortage of organs, i as well has to exist realistic with patients.

At the moment, the function of morphine and nesiritide remain questionable and requires further evaluation.[27][28]

Outcomes

Unfortunately, despite optimal handling, the outcomes for cardiogenic pulmonary edema/center failure are abysmal. There is no cure for this disorder, and the central is to preclude the condition in the first place.

Review Questions

Figure

Kerley lines in Congestive heart failure. Epitome courtesy of Due south bhimji MD

References

1.: Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and direction. Am Fam Physician. 2013 Jul fifteen;88(2):102-10. [PubMed: 23939641]
two.: Powell J, Graham D, O'Reilly Southward, Punton G. Acute pulmonary oedema. Nurs Stand. 2016 Feb 03;30(23):51-ix; quiz threescore. [PubMed: 26838657]
three.: Sureka B, Bansal K, Arora A. Pulmonary edema - cardiogenic or noncardiogenic? J Family Med Prim Care. 2015 April-Jun;4(2):290. [PMC free article: PMC4408723] [PubMed: 25949989]
four.: Alwi I. Diagnosis and direction of cardiogenic pulmonary edema. Acta Med Indones. 2010 Jul;42(iii):176-84. [PubMed: 20973297]
5.: Platz E, Jhund PS, Campbell RT, McMurray JJ. Assessment and prevalence of pulmonary oedema in contemporary acute centre failure trials: a systematic review. Eur J Heart Fail. 2015 Sep;17(9):906-xvi. [PMC free commodity: PMC4725064] [PubMed: 26230356]
6.: Crane SD. Epidemiology, handling and outcome of acidotic, astute, cardiogenic pulmonary oedema presenting to an emergency department. Eur J Emerg Med. 2002 Dec;9(iv):320-iv. [PubMed: 12501030]
7.: Wiener RS, Moses HW, Richeson JF, Gatewood RP. Hospital and long-term survival of patients with astute pulmonary edema associated with coronary avenue disease. Am J Cardiol. 1987 Jul 01;60(one):33-v. [PubMed: 3604942]
8.: Murray JF. Pulmonary edema: pathophysiology and diagnosis. Int J Tuberc Lung Dis. 2011 February;15(2):155-lx, i. [PubMed: 21219673]
9.: Sibbald WJ, Anderson RR, Holliday RL. Pathogenesis of pulmonary edema associated with the adult respiratory distress syndrome. Can Med Assoc J. 1979 Feb 17;120(4):445-50. [PMC free article: PMC1818907] [PubMed: 376080]
ten.: Miles WA. Pulmonary edema: an anatomic, pathophysiologic, and roentgenologic analysis. J Natl Med Assoc. 1977 Mar;69(3):179-82. [PMC gratis article: PMC2637658] [PubMed: 875070]
11.: Guntupalli KK. Acute pulmonary edema. Cardiol Clin. 1984 May;two(ii):183-200. [PubMed: 6443344]
12.: Mattu A, Martinez JP, Kelly BS. Modern direction of cardiogenic pulmonary edema. Emerg Med Clin North Am. 2005 Nov;23(iv):1105-25. [PubMed: 16199340]
13.: Matsuyama S, Ootaki M, Saito T, Iino Thousand, Kano M. [Radiographic diagnosis of cardiogenic pulmonary edema]. Nihon Igaku Hoshasen Gakkai Zasshi. 1999 May;59(half-dozen):223-30. [PubMed: 10388306]
14.: Johnson MR. Astute Pulmonary Edema. Curr Care for Options Cardiovasc Med. 1999 Oct;1(3):269-276. [PubMed: 11096492]
fifteen.: Sánchez Marteles M, Urrutia A. [Astute center failure: acute cardiogenic pulmonary edema and cardiogenic shock]. Med Clin (Barc). 2014 Mar;142 Suppl i:14-nine. [PubMed: 24930078]
xvi.: Baird A. Acute pulmonary oedema - management in general practice. Aust Fam Physician. 2010 Dec;39(12):910-4. [PubMed: 21301670]
17.: Chioncel O, Collins SP, Ambrosy AP, Gheorghiade M, Filippatos G. Pulmonary Oedema-Therapeutic Targets. Card Neglect Rev. 2015 Apr;ane(1):38-45. [PMC free article: PMC5491006] [PubMed: 28785430]
xviii.: Johnson JM. Management of astute cardiogenic pulmonary edema: a literature review. Adv Emerg Nurs J. 2009 Jan-Mar;31(ane):36-43. [PubMed: 20118852]
19.: WRITING Commission MEMBERS. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL., American College of Cardiology Foundation/American Eye Clan Task Strength on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a written report of the American Higher of Cardiology Foundation/American Center Association Task Forcefulness on practice guidelines. Apportionment. 2013 Oct xv;128(16):e240-327. [PubMed: 23741058]
20.: Matsue Y, Damman One thousand, Voors AA, Kagiyama N, Yamaguchi T, Kuroda South, Okumura T, Kida K, Mizuno A, Oishi Southward, Inuzuka Y, Akiyama East, Matsukawa R, Kato M, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida M, Kitai T. Time-to-Furosemide Treatment and Bloodshed in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. [PubMed: 28641794]
21.: O'Connor CM, Starling RC, Hernandez AF, Armstrong Pow, Dickstein K, Hasselblad Five, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup South, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated middle failure. N Engl J Med. 2011 Jul 07;365(1):32-43. [PubMed: 21732835]
22.: Marenzi Thousand, Grazi S, Giraldi F, Lauri G, Perego One thousand, Guazzi M, Salvioni A, Guazzi MD. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive middle failure: effects of extracorporeal ultrafiltration. Am J Med. 1993 January;94(i):49-56. [PubMed: 8420299]
23.: Coraim FI, Wolner E. Continuous hemofiltration for the declining heart. New Horiz. 1995 Nov;3(4):725-31. [PubMed: 8574603]
24.: Fiaccadori E, Regolisti G, Maggiore U, Parenti E, Cremaschi E, Detrenis S, Caiazza A, Cabassi A. Ultrafiltration in heart failure. Am Heart J. 2011 Mar;161(3):439-49. [PubMed: 21392597]
25.: Komiya K, Akaba T, Kozaki Y, Kadota JI, Rubin BK. A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema. Crit Care. 2017 Aug 25;21(i):228. [PMC free article: PMC6389074] [PubMed: 28841896]
26.: Potts JM. Noninvasive positive pressure ventilation: result on bloodshed in astute cardiogenic pulmonary edema: a pragmatic meta-analysis. Political leader Curvation Med Wewn. 2009 Jun;119(vi):349-53. [PubMed: 19694215]
27.: Ellingsrud C, Agewall Due south. Morphine in the handling of acute pulmonary oedema--Why? Int J Cardiol. 2016 January 01;202:870-3. [PubMed: 26476045]
28.: Howlett JG. Current treatment options for early management in acute decompensated middle failure. Tin J Cardiol. 2008 Jul;24 Suppl B:9B-14B. [PMC free commodity: PMC2794440] [PubMed: 18629382]

cartercaget1989.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/books/NBK544260/